| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |